Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2)
i
Other names:
NTRK2, TRKB, Neurotrophic tyrosine kinase, receptor, type 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4915
Related tests:
‹
FoundationOne® CDx (110)
OncoDEEP (3)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
AmoyDx® Pan Lung Cancer PCR Panel (1)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
Idylla™ GeneFusion Assay (1)
Trailblaze Pharos™ (1)
ACTOnco
ASPYRE-Lung
AVENIO Tumor Tissue CGP Kit
Altera
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® NTRK Gene Fusions Detection Kit
Archer® FusionPlex® Oncology Research Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Aventa FusionPlus Test
FusionPlex® Dx
FusionPlex® Pan Solid Tumor v2 panel
GALEAS™ Tumor
HDPCR NSCLC RUO Assay
Liquid Trace™ Solid Tumor
NeXT Dx™ Test
NexCourse®
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoPM™ 2.0
OncoGuide™ NCC Oncopanel System
OncoSTRAT&GO
Oncomine Dx Express Test
Oncomine Focus Assay
Oncomine Precision Assay
Oncomine™ Comprehensive Assay Plus
Oncotype MAP™ Pan-Cancer Tissue Test
PGDx elio™ tissue complete assay
SOPHiA DDM Dx RNAtarget Oncology Solution
Tempus xF+ Panel
TruSight Oncology Comprehensive
VENTANA pan-TRK (EPR17341) Assay
oncoReveal™ Fusion LBx Panel
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
FoundationOne® CDx (110)
OncoDEEP (3)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
AmoyDx® Pan Lung Cancer PCR Panel (1)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
Idylla™ GeneFusion Assay (1)
Trailblaze Pharos™ (1)
ACTOnco
ASPYRE-Lung
AVENIO Tumor Tissue CGP Kit
Altera
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® NTRK Gene Fusions Detection Kit
Archer® FusionPlex® Oncology Research Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Aventa FusionPlus Test
FusionPlex® Dx
FusionPlex® Pan Solid Tumor v2 panel
GALEAS™ Tumor
HDPCR NSCLC RUO Assay
Liquid Trace™ Solid Tumor
NeXT Dx™ Test
NexCourse®
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoPM™ 2.0
OncoGuide™ NCC Oncopanel System
OncoSTRAT&GO
Oncomine Dx Express Test
Oncomine Focus Assay
Oncomine Precision Assay
Oncomine™ Comprehensive Assay Plus
Oncotype MAP™ Pan-Cancer Tissue Test
PGDx elio™ tissue complete assay
SOPHiA DDM Dx RNAtarget Oncology Solution
Tempus xF+ Panel
TruSight Oncology Comprehensive
VENTANA pan-TRK (EPR17341) Assay
oncoReveal™ Fusion LBx Panel
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
›
Associations
(107)
News
Trials
VERI cancer hierarchy
Reset Filters
NTRK2 fusion
Solid Tumor
NTRK2 fusion
Solid Tumor
repotrectinib
Sensitive: A1 - Approval
repotrectinib
Sensitive
:
A1
repotrectinib
Sensitive: A1 - Approval
repotrectinib
Sensitive
:
A1
NTRK2 fusion
Sarcoma
NTRK2 fusion
Sarcoma
larotrectinib
Sensitive: A1 - Approval
larotrectinib
Sensitive
:
A1
larotrectinib
Sensitive: A1 - Approval
larotrectinib
Sensitive
:
A1
NTRK2 fusion
Solid Tumor
NTRK2 fusion
Solid Tumor
larotrectinib
Sensitive: A1 - Approval
larotrectinib
Sensitive
:
A1
larotrectinib
Sensitive: A1 - Approval
larotrectinib
Sensitive
:
A1
NTRK2 fusion
Solid Tumor
NTRK2 fusion
Solid Tumor
entrectinib
Sensitive: A1 - Approval
entrectinib
Sensitive
:
A1
entrectinib
Sensitive: A1 - Approval
entrectinib
Sensitive
:
A1
NTRK2 fusion
Small Intestinal Carcinoma
NTRK2 fusion
Small Intestinal Carcinoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK2 fusion
Thyroid Gland Follicular Carcinoma
NTRK2 fusion
Thyroid Gland Follicular Carcinoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK2 fusion
Thyroid Gland Oncocytic Carcinoma
NTRK2 fusion
Thyroid Gland Oncocytic Carcinoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK2 fusion
Thyroid Gland Follicular Carcinoma
NTRK2 fusion
Thyroid Gland Follicular Carcinoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Pancreatic Adenocarcinoma
NTRK2 fusion
Pancreatic Adenocarcinoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Gastrointestinal Stromal Tumor
NTRK2 fusion
Gastrointestinal Stromal Tumor
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK2 fusion
Breast Cancer
NTRK2 fusion
Breast Cancer
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK2 fusion
Peritoneal Cancer
NTRK2 fusion
Peritoneal Cancer
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.